tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Alnylam: Near-Term Amvuttra Shortfall Outweighed by Robust TTR Growth Outlook and Strengthened Long-Term Leadership Position
PremiumRatingsAlnylam: Near-Term Amvuttra Shortfall Outweighed by Robust TTR Growth Outlook and Strengthened Long-Term Leadership Position
18d ago
Alnylam Pharmaceuticals: Strong Long-Term Growth Strategy But Balanced Risk/Reward Supports Hold Rating
Premium
Ratings
Alnylam Pharmaceuticals: Strong Long-Term Growth Strategy But Balanced Risk/Reward Supports Hold Rating
18d ago
Alnylam 2026 guidance reflects continued momentum, says H.C. Wainwright
Premium
The Fly
Alnylam 2026 guidance reflects continued momentum, says H.C. Wainwright
18d ago
Alnylam price target lowered to $530 from $535 at Truist
PremiumThe FlyAlnylam price target lowered to $530 from $535 at Truist
22d ago
Alnylam assumed with an Outperform at Oppenheimer
Premium
The Fly
Alnylam assumed with an Outperform at Oppenheimer
23d ago
Alnylam price target lowered to $491 from $525 at Bernstein
Premium
The Fly
Alnylam price target lowered to $491 from $525 at Bernstein
24d ago
Alnylam price target lowered to $351 from $370 at Leerink
PremiumThe FlyAlnylam price target lowered to $351 from $370 at Leerink
2M ago
BridgeBio price target raised to $86 from $75 at Leerink
Premium
The Fly
BridgeBio price target raised to $86 from $75 at Leerink
2M ago
Nasdaq adding Alnylam, Ferrovial, Insmed, Monolithic Power at open on 12/22
Premium
The Fly
Nasdaq adding Alnylam, Ferrovial, Insmed, Monolithic Power at open on 12/22
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100